Behcet's syndrome pathophysiology and potential therapeutic targets

被引:51
|
作者
Emmi, Giacomo [1 ]
Silvestri, Elena [1 ,2 ,3 ]
Squatrito, Danilo [2 ,3 ]
D'Elios, Mario Milco [1 ,2 ,3 ]
Ciucciarelli, Lucia [1 ]
Prisco, Domenico [1 ,2 ,3 ]
Emmi, Lorenzo [2 ,3 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[2] AOU Careggi, SOD Patol Med, Ctr Autoimmune Syst Dis, Behcet Ctr, Florence, Italy
[3] AOU Careggi, Lupus Clin, Florence, Italy
关键词
Behcet syndrome pathophysiology; Behcet treatment; Biologic therapy; Anti-TNF-alpha; IL-1 blocking agents; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; V-GAMMA-9/V-DELTA-2; T-LYMPHOCYTES; FAMILIAL MEDITERRANEAN FEVER; INTERFERON ALPHA-2A; STREPTOCOCCUS-SANGUIS; DOUBLE-BLIND; TNF FAMILY; DISEASE; UVEITIS;
D O I
10.1007/s11739-013-1036-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behcet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behcet syndrome pathogenesis and their potential role as novel therapeutic targets.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [21] Behcet's Syndrome
    Hatemi, Gulen
    Yazici, Yusuf
    Yazici, Hasan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2013, 39 (02) : 245 - +
  • [22] Behcet's syndrome
    Stanford, MR
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) : 381 - 382
  • [23] Behcet's syndrome: providing integrated care
    Esatoglu, Sinem Nihal
    Kutlubay, Zekayi
    Ucar, Didar
    Hatemi, Ibrahim
    Uygunoglu, Ugur
    Siva, Aksel
    Hatemi, Gulen
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2017, 10 : 309 - 319
  • [24] Behcet's syndrome and micro-organisms
    Hatemi, Gulen
    Yazici, Hasan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (03): : 389 - 406
  • [25] No appreciable decrease in fertility in Behcet's syndrome
    Uzunaslan, Didem
    Saygin, Caner
    Hatemi, Gulen
    Tascilar, Koray
    Yazici, Hasan
    RHEUMATOLOGY, 2014, 53 (05) : 828 - 833
  • [26] Treating the Different Phenotypes of Behcet's Syndrome
    Bettiol, Alessandra
    Hatemi, Gulen
    Vannozzi, Lorenzo
    Barilaro, Alessandro
    Prisco, Domenico
    Emmi, Giacomo
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [27] Animal models of preeclampsia: investigating pathophysiology and therapeutic targets
    Bakrania, Bhavisha A.
    George, Eric M.
    Granger, Joey P.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : S973 - S987
  • [28] Pathophysiology of hemophilic arthropathy and potential targets for therapy
    Pulles, Astrid E.
    Mastbergen, Simon C.
    Schutgens, Roger E. G.
    Lafeber, Floris P. J. G.
    van Vulpen, Lize F. D.
    PHARMACOLOGICAL RESEARCH, 2017, 115 : 192 - 199
  • [29] Sjogren's syndrome: from pathogenesis to novel therapeutic targets
    Barone, F.
    Colafrancesco, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S58 - S62
  • [30] S100-alarmins: potential therapeutic targets for arthritis
    Austermann, Judith
    Zenker, Stefanie
    Roth, Johannes
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (07) : 739 - 751